Food flavors on the breath may reveal hidden liver disease
NCT ID NCT05935488
First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time
Summary
This study explores whether a simple breath test can detect early liver fibrosis in people with non-alcoholic steatohepatitis (NASH). Participants fast overnight, then drink a mixture of food-grade flavor compounds and provide breath samples over 90 minutes. The way the body processes these flavors may change with liver disease, offering a potential non-invasive diagnostic tool.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- food-grade flavor compounds (Exogenous Volatile Organic Compounds)
- What this could lead to
- If successful, this could lead to a simple, non-invasive breath test to detect early liver fibrosis, reducing the need for biopsies.
- What could go wrong
- This is a very small early study with only one participant, so results may not apply to others. The breath test may not reliably distinguish between healthy and diseased livers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
1 person
The number who actually took part.
- Started
-
May 2024
- Finished
-
Dec 2024
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
A total of 30 subjects with fibroscan confirmed liver fibrosis likely due to NASH will be recruited. To be eligible for the study participation, subjects must meet the inclusion and exclusion criteria.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Able to provide written informed consent. * \>18 years old. * Body weight \> 50 kg. * Alcohol consumption - does not drink to excess (\>30 g/day in men, \>20 g/day in women). * Fibroscan kilopascal (kPa) between 8.5 and 13.5 within 6 months and/or a liver biopsy within the last 3 years showing a fibrosis activity score ≥ F2 and a NAS score \> 4 with a diagnosis of non alcoholic steatohepatitis (NASH) Exclusion Criteria: * (Anticipated) inability to complete the breath sampling procedure due to e.g. inability to maintain adequate ventilation unaided or claustrophobia / Inability to comply with the study procedures in the opinion of the investigator. * Participant has cirrhosis. * Participant has current hepatocellular carcinoma (HCC) or currently being treated for HCC. Those previously with/treated for and now clear of HCC can be recruited. * Participant's cause of liver disease is known to be one of alcohol abuse, hepatitis, autoimmune hepatitis, medications, haemochromatosis, alpha1 antitrypsin deficiency, Wilson disease, biliary problems. * Presence of current common cold or any other infectious disease including any recent symptoms of Covid-19. * Participant is known to be pregnant or breast feeding. * Participant with a diagnosis of chronic, active gastritis * Participant is affected by asthma, chronic obstructive pulmonary disease (COPD), and/or airway hyperactivity. * Known intolerances and/or allergies (\*) to any food containing tested compounds. For limonene, citrus fruits, and fruit juices. For benzyl alcohol, apricots, cranberries, and cocoa. For 2-pentanone cheddar cheese, ripe bananas, and defatted soybean flour. For 2-butanol cheddar cheese and yogurt. For nonanal, apple, avocado, black currants, cooked beef, cucumber, fish, grapefruit, lemon, lime, mandarin, orange, and peach.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Liver diseases are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
North Norfolk Primary Care
Norwich, Norfolk, NR11RB, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could type 1 diabetes hide liver problems in children?
- Can software make hospital pharmacists faster and safer?
- A smartphone app may help curb the silent march of fatty liver disease toward cirrhosis
- Can gut microbes hold the key to liver health?
- AI and blood biomarkers could catch hidden liver damage
- Can stem cells help infants with biliary atresia avoid a liver transplant?